(42 days)
Not Found
Not Found
No
The summary describes reagents for a chemistry analyzer and does not mention any AI or ML components.
No
The device is described as a reagent for in vitro diagnostic use, intended for the measurement of urea nitrogen and creatinine in serum and plasma, which aids in the diagnosis and treatment of certain diseases. It does not provide therapy or treatment itself.
Yes
The document states that the reagents are "for in vitro diagnostic use only" and that the measurements they enable are "used for the diagnosis and treatment of certain renal and metabolic diseases" and "used in the diagnosis and treatment of renal diseases." This clearly indicates their role in diagnosis.
No
The device described is a reagent, which is a chemical substance used in a laboratory test. It is intended for use with a "chemistry analyzer," which is a hardware device. The summary does not describe any software component that functions as a medical device on its own.
Yes, based on the provided information, this device is an IVD (In Vitro Diagnostic).
Here's why:
- Explicit Statement: Both reagent descriptions clearly state "For in vitro diagnostic use only." This is a direct indication that the product is intended for diagnostic purposes outside of a living organism.
- Intended Use: The intended use for both reagents is the measurement of specific substances (urea nitrogen and creatinine) in biological samples (serum and plasma) for the diagnosis and treatment of diseases. This aligns with the definition of an IVD.
- Measurement of Analytes: IVDs are designed to measure analytes in biological specimens to provide information for diagnosis, monitoring, or treatment. The EasyRA reagents do exactly this.
N/A
Intended Use / Indications for Use
EasyRA BUN Reagent:
The EasyRA Urea Nitrogen (BUN) Reagent is for the measurement of urea nitrogen in serum and plasma using the "EasyRA chemistry analyzer". Urea measurements are used for the diagnosis and treatment of certain renal and metabolic diseases.
For in vitro diagnostic use only.
EasyRA CREA Reagent:
The EasyRA Creatinine (CREA) Reagent is for the measurement of Creatinine in serum and plasma using the "EasyRA chemistry analyzer". Creatinine measurements are used in the diagnosis and treatment of renal diseases, in monitoring renal dialysis.
For in vitro diagnostic use only.
Product codes
CDQ, CGX
Device Description
Not Found
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Not Found
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
Not Found
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 862.1770 Urea nitrogen test system.
(a)
Identification. A urea nitrogen test system is a device intended to measure urea nitrogen (an end-product of nitrogen metabolism) in whole blood, serum, plasma, and urine. Measurements obtained by this device are used in the diagnosis and treatment of certain renal and metabolic diseases.(b)
Classification. Class II.
0
Public Health Service
DEPARTMENT OF HEALTH & HUMAN SERVICES
Image /page/0/Picture/2 description: The image shows a circular seal with the words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" arranged around the perimeter. Inside the circle is a stylized emblem consisting of three parallel, curved lines that converge to the right, resembling a bird in flight. The emblem is a symbol associated with the U.S. Department of Health and Human Services.
Food & Drug Administration 10903 New Hampshire Avenue Building 66 Silver Spring, MD 20993
APR 2 1 2011
Medica Corporation c/o Dr. Photios Makris Director of Regulatory Affairs 5 Oak Park Drive Bedford. MA 01730
Re: K110675 Trade Name: EasyRA Bun Reagent, EasyRA CREA Reagent Regulation Number: 21 CFR §862.1770 Regulation Name: Urea Nitrogen Test System. Regulatory Class: Class II Product Codes: CDQ, CGX Dated: March 08, 2011 Received: March 10, 2011
Dear Dr. Makris:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in Title 21, Code of Federal Regulations (CFR), Parts 800 to 895. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Parts 801 and 809); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); and good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820).
1
Page 2 -
1f you desire specific advice for your device on our labeling regulation (21 CFR Parts 801 and 809), please contact the Office of In Vitro Diagnostic Device Evaluation and Safety at (301) 796-5450. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.
Sincerely yours,
CJC.
Courtney Harper, Ph.D. Director Division of Chemistry and Toxicology Office of In Vitro Diagnostic Device Evaluation and Safety Center for Devices and Radiological Health
Enclosure
2
Indications for Use
510(k) Number (if known): K110675
Device Name: EasyRA Urea Nitrogen reagent EasyRA Creatinine reagent
Indications For Use:
EasyRA BUN Reagent:
The EasyRA Urea Nitrogen (BUN) Reagent is for the measurement of urea nitrogen in serum and plasma using the "EasyRA chemistry analyzer". Urea measurements are used for the diagnosis and treatment of certain renal and metabolic diseases.
For in vitro diagnostic use only.
EasyRA CREA Reagent:
The EasyRA Creatinine (CREA) Reagent is for the measurement of Creatinine in serum and plasma using the "EasyRA chemistry analyzer". Creatinine measurements are used in the diagnosis and treatment of renal diseases, in monitoring renal dialysis.
For in vitro diagnostic use only.
Prescription Use X (21 CFR Part 801 Subpart D) And/Or
Over the Counter Use (21 CFR Part 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE; CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of In Vitro Diagnostic Device Evaluation and Safety (OVD)
Apr
Division Sign-Off Office of In Vitro Diagnostic Device Evaluation and Safety
510(k) K110675